Document Detail


Frequency of pregnancy-related venous thromboembolism in anticoagulant factor-deficient women: implications for prophylaxis.
MedLine Citation:
PMID:  8967705     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: It has been reported that women with an inherited deficiency of antithrombin, protein C, or protein S have an increased risk for developing venous thromboembolic disease during pregnancy and the postpartum period. However, because the available data on risk are flawed, it is difficult to define a rational, efficacious, and safe policy about prophylaxis for venous thromboembolism in these women. OBJECTIVE: To determine the frequency of venous thromboembolism during pregnancy and the postpartum period in women with heritable deficiencies of anticoagulant factors. DESIGN: Retrospective cohort study. SETTING: University outpatient clinics in the Netherlands and Italy. PARTICIPANTS: 129 otherwise asymptomatic female family members of patients with a history of venous thromboembolism and an established deficiency of antithrombin, protein C, or protein S. MEASUREMENTS: Medical history, with specific attention to episodes of venous thromboembolism and obstetric history, was taken. The anticoagulant factor status of the study participants was determined. If a patient had an episode of venous thromboembolism, subsequent pregnancies in that patient were not analyzed. RESULTS: Of the 129 women who participated in the study, 60 had anticoagulant factor deficiency and 69 did not. In the nondeficient group, 198 pregnancies occurred; 1 of these (0.5%) was complicated by an episode of venous thromboembolism during the postpartum period. In the deficient group, 169 pregnancies occurred; 7 of these (4.1%) were complicated by an episode of venous thromboembolism during the third trimester of pregnancy (2 pregnancies [1.2%]) and the postpartum period (5 pregnancies [3.0%]). The risk for venous thromboembolism was increased eightfold in deficient women compared with nondeficient women (hazard ratio, 8.0 [95% CI 1.2 to 184]). CONCLUSIONS: Anticoagulant factor-deficient women have an increased risk for venous thromboembolism during pregnancy and the postpartum period. Although data from an appropriate randomized clinical trial are lacking, the frequency of venous thromboembolism seen in deficient women might justify the use of anticoagulative prophylaxis during the third trimester of pregnancy and the postpartum period.
Authors:
P W Friederich; B J Sanson; P Simioni; S Zanardi; M V Huisman; I Kindt; P Prandoni; H R Büller; A Girolami; M H Prins
Related Documents :
21830245 - Influence of chorionicity on perinatal outcome in a large cohort of danish twin pregnan...
11213005 - Venous thromboembolism in pregnancy and the puerperium: incidence and additional risk f...
1078885 - Thromboembolism in pregnancy.
22394735 - 13 ultrasound evaluation of fetal and placental development in somatic cell nuclear tra...
16506115 - Domestic violence during pregnancy in turkey and responsibility of prenatal healthcare ...
10494465 - Intrauterine resuscitation of the compromised fetus.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Annals of internal medicine     Volume:  125     ISSN:  0003-4819     ISO Abbreviation:  Ann. Intern. Med.     Publication Date:  1996 Dec 
Date Detail:
Created Date:  1996-12-19     Completed Date:  1996-12-19     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0372351     Medline TA:  Ann Intern Med     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  955-60     Citation Subset:  AIM; IM    
Affiliation:
Academic Medical Center, Amsterdam, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Antithrombin III Deficiency*
Cohort Studies
Female
Heparin, Low-Molecular-Weight / therapeutic use
Humans
Incidence
Infant, Newborn
Pregnancy
Pregnancy Complications, Cardiovascular / blood,  epidemiology*,  prevention & control
Protein C Deficiency*
Protein S Deficiency / complications*
Puerperal Disorders / blood,  epidemiology*,  prevention & control
Retrospective Studies
Risk Factors
Thromboembolism / blood,  epidemiology*,  prevention & control
Chemical
Reg. No./Substance:
0/Heparin, Low-Molecular-Weight
Comments/Corrections
Comment In:
Ann Intern Med. 1997 Jul 15;127(2):164   [PMID:  9230012 ]
Ann Intern Med. 1997 Jul 15;127(2):163-4   [PMID:  9230011 ]
Ann Intern Med. 1997 Jul 15;127(2):164-5   [PMID:  9230013 ]
Ann Intern Med. 1996 Dec 15;125(12):1001-3   [PMID:  8967687 ]
Erratum In:
Ann Intern Med 1997 May 15;126(10):835
Ann Intern Med 1997 Dec 15;127(12):1138

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effect of apheresis of low-density lipoprotein on peripheral vascular disease in hypercholesterolemi...
Next Document:  Calcium and vitamin D3 supplementation prevents bone loss in the spine secondary to low-dose cortico...